- Home
- / Boehringer Ingelheim
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Boehringer Ingelheim financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
€8.9 B
FY, 2021
CreditSafe Score
?
Score changed on Mar 28, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 8.5B | 8.8B | 8.9B |
| Cost of goods sold | 2.5B | 2.9B | 3.0B |
| Gross profit | 5.9B | 6.0B | 6.0B |
| Gross profit margin, % | 70.2% | 67.6% | 66.9% |
| General and administrative expense | 215.0M | 235.9M | 262.4M |
| Operating expense total | 5.2B | 5.6B | 6.0B |
| Depreciation and amortization | 112.5M | 131.7M | 51.7M |
| EBIT | 2.2B | 1.8B | 1.3B |
| EBIT margin, % | 26.5% | 20.6% | 14.8% |
| Investment income | 207.1M | 6.7M | 9.2M |
| Interest income | 33.0M | 36.5M | 21.3M |
| Interest expense | 48.9M | 46.4M | 46.8M |
| Pre tax profit | 2.5B | 3.5B | 2.2B |
| Income tax expense | 955.0K | (2.9M) | |
| Net Income | 2.5B | 3.5B | 2.2B |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |